FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background. Currently, ferritin heavy chain (FTH1) has been increasingly found to play a crucial role in cancer as a core regulator of ferroptosis, while its role of non-ferroptosis in head and neck squamous cell carcinoma (HNSCC) is still unclear. Methods. Herein, we analyzed the expression level of FTH1 in HNSCC using TCGA database, and FTH1 protein in HNSCC tissues and cell lines was determined by immunohistochemistry (IHC) and western blotting, respectively. Then, its prognostic value and relationship with clinical parameters were investigated in HNSCC patients. Additionally, the biological function of FTH1 in HNSCC was explored. Results. The current study showed that FTH1 is significantly overexpressed in HNSCC tissues and related to poor prognosis and lymph node metastasis of HNSCC. FTH1 knockdown could suppress the metastasis and epithelial-mesenchymal transition (EMT) process of HNSCC. Conclusion. Our findings indicate that FTH1 plays a critical role in the progression and metastasis of HNSCC and can serve as a promising prognostic factor and therapeutic target in HNSCC.

Cite

CITATION STYLE

APA

Liao, Q., Yang, J., Lu, Z., Jiang, Q., Gong, Y., Liu, L., … Liu, Z. (2023). FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma. PeerJ, 11. https://doi.org/10.7717/peerj.16493

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free